Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

The HSP70 modulator MAL3-101 inhibits Merkel cell carcinoma.

Adam C, Baeurle A, Brodsky JL, Wipf P, Schrama D, Becker JC, Houben R.

PLoS One. 2014 Apr 2;9(4):e92041. doi: 10.1371/journal.pone.0092041. eCollection 2014.

2.

Survivin is a therapeutic target in Merkel cell carcinoma.

Arora R, Shuda M, Guastafierro A, Feng H, Toptan T, Tolstov Y, Normolle D, Vollmer LL, Vogt A, Dömling A, Brodsky JL, Chang Y, Moore PS.

Sci Transl Med. 2012 May 9;4(133):133ra56. doi: 10.1126/scitranslmed.3003713.

3.

High-affinity Rb binding, p53 inhibition, subcellular localization, and transformation by wild-type or tumor-derived shortened Merkel cell polyomavirus large T antigens.

Borchert S, Czech-Sioli M, Neumann F, Schmidt C, Wimmer P, Dobner T, Grundhoff A, Fischer N.

J Virol. 2014 Mar;88(6):3144-60. doi: 10.1128/JVI.02916-13. Epub 2013 Dec 26.

4.

Mechanisms of p53 restriction in Merkel cell carcinoma cells are independent of the Merkel cell polyoma virus T antigens.

Houben R, Dreher C, Angermeyer S, Borst A, Utikal J, Haferkamp S, Peitsch WK, Schrama D, Hesbacher S.

J Invest Dermatol. 2013 Oct;133(10):2453-2460. doi: 10.1038/jid.2013.169. Epub 2013 Apr 5.

5.

Response of Merkel cell polyomavirus-positive merkel cell carcinoma xenografts to a survivin inhibitor.

Dresang LR, Guastafierro A, Arora R, Normolle D, Chang Y, Moore PS.

PLoS One. 2013 Nov 18;8(11):e80543. doi: 10.1371/journal.pone.0080543. eCollection 2013.

6.

Characterization of functional domains in the Merkel cell polyoma virus Large T antigen.

Houben R, Angermeyer S, Haferkamp S, Aue A, Goebeler M, Schrama D, Hesbacher S.

Int J Cancer. 2015 Mar 1;136(5):E290-300. doi: 10.1002/ijc.29200. Epub 2014 Sep 19.

7.

The T antigen locus of Merkel cell polyomavirus downregulates human Toll-like receptor 9 expression.

Shahzad N, Shuda M, Gheit T, Kwun HJ, Cornet I, Saidj D, Zannetti C, Hasan U, Chang Y, Moore PS, Accardi R, Tommasino M.

J Virol. 2013 Dec;87(23):13009-19. doi: 10.1128/JVI.01786-13. Epub 2013 Sep 25.

8.

Merkel cell polyomavirus small T antigen targets the NEMO adaptor protein to disrupt inflammatory signaling.

Griffiths DA, Abdul-Sada H, Knight LM, Jackson BR, Richards K, Prescott EL, Peach AH, Blair GE, Macdonald A, Whitehouse A.

J Virol. 2013 Dec;87(24):13853-67. doi: 10.1128/JVI.02159-13. Epub 2013 Oct 9.

9.

Merkel cell polyomavirus recruits MYCL to the EP400 complex to promote oncogenesis.

Cheng J, Park DE, Berrios C, White EA, Arora R, Yoon R, Branigan T, Xiao T, Westerling T, Federation A, Zeid R, Strober B, Swanson SK, Florens L, Bradner JE, Brown M, Howley PM, Padi M, Washburn MP, DeCaprio JA.

PLoS Pathog. 2017 Oct 13;13(10):e1006668. doi: 10.1371/journal.ppat.1006668. eCollection 2017 Oct.

10.

Merkel cell polyomavirus infection, large T antigen, retinoblastoma protein and outcome in Merkel cell carcinoma.

Sihto H, Kukko H, Koljonen V, Sankila R, Böhling T, Joensuu H.

Clin Cancer Res. 2011 Jul 15;17(14):4806-13. doi: 10.1158/1078-0432.CCR-10-3363. Epub 2011 Jun 3.

11.

Merkel cell polyomavirus-positive Merkel cell carcinoma cells do not require expression of the viral small T antigen.

Angermeyer S, Hesbacher S, Becker JC, Schrama D, Houben R.

J Invest Dermatol. 2013 Aug;133(8):2059-64. doi: 10.1038/jid.2013.82. Epub 2013 Feb 25.

12.

Characterization of an early passage Merkel cell polyomavirus-positive Merkel cell carcinoma cell line, MS-1, and its growth in NOD scid gamma mice.

Guastafierro A, Feng H, Thant M, Kirkwood JM, Chang Y, Moore PS, Shuda M.

J Virol Methods. 2013 Jan;187(1):6-14. doi: 10.1016/j.jviromet.2012.10.001. Epub 2012 Oct 18.

13.

Distinct merkel cell polyomavirus molecular features in tumour and non tumour specimens from patients with merkel cell carcinoma.

Laude HC, Jonchère B, Maubec E, Carlotti A, Marinho E, Couturaud B, Peter M, Sastre-Garau X, Avril MF, Dupin N, Rozenberg F.

PLoS Pathog. 2010 Aug 26;6(8):e1001076. doi: 10.1371/journal.ppat.1001076.

14.

[Merkel cell carcinoma revisited: a new example of viro-induced human tumour].

Sastre-Garau X.

Pathol Biol (Paris). 2011 Apr;59(2):127-30. doi: 10.1016/j.patbio.2010.07.007. Review. French.

PMID:
20817373
15.

Merkel cell polyomavirus-infected Merkel cell carcinoma cells require expression of viral T antigens.

Houben R, Shuda M, Weinkam R, Schrama D, Feng H, Chang Y, Moore PS, Becker JC.

J Virol. 2010 Jul;84(14):7064-72. doi: 10.1128/JVI.02400-09. Epub 2010 May 5.

16.

Merkel cell carcinoma with heterologous rhabdomyoblastic differentiation: the role of immunohistochemistry for Merkel cell polyomavirus large T-antigen in confirmation.

Adhikari LA, McCalmont TH, Folpe AL.

J Cutan Pathol. 2012 Jan;39(1):47-51. doi: 10.1111/j.1600-0560.2011.01794.x. Epub 2011 Oct 28.

PMID:
22032237
17.

Type I and II IFNs inhibit Merkel cell carcinoma via modulation of the Merkel cell polyomavirus T antigens.

Willmes C, Adam C, Alb M, Völkert L, Houben R, Becker JC, Schrama D.

Cancer Res. 2012 Apr 15;72(8):2120-8. doi: 10.1158/0008-5472.CAN-11-2651. Epub 2012 Mar 2.

18.

Merkel cell polyomavirus: a newly discovered human virus with oncogenic potential.

Spurgeon ME, Lambert PF.

Virology. 2013 Jan 5;435(1):118-30. doi: 10.1016/j.virol.2012.09.029. Review.

19.

MicroRNA expression patterns related to merkel cell polyomavirus infection in human merkel cell carcinoma.

Xie H, Lee L, Caramuta S, Höög A, Browaldh N, Björnhagen V, Larsson C, Lui WO.

J Invest Dermatol. 2014 Feb;134(2):507-517. doi: 10.1038/jid.2013.355. Epub 2013 Aug 20.

20.

The Merkel cell polyomavirus and its involvement in Merkel cell carcinoma.

Amber K, McLeod MP, Nouri K.

Dermatol Surg. 2013 Feb;39(2):232-8. doi: 10.1111/dsu.12079. Review.

PMID:
23387356

Supplemental Content

Support Center